Essex Investment Management’s Repligen RGEN Stock Holding History

Essex Investment Management’s Portfolio RGEN Stock Details RGEN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-178	Closed	-$30K	–	402
2023 Q1	$30K	Hold	178	–	–	﹤0.01%	336
2022 Q4	$30K	Hold	178	–	–	﹤0.01%	333
2022 Q3	$33K	Hold	178	–	–	0.01%	327
2022 Q2	$29K	Sell	178 -534	-75%	-$84.5K	﹤0.01%	338
2022 Q1	$134K	Hold	712	–	–	0.02%	308
2021 Q4	$189K	Hold	712	–	–	0.02%	312
2021 Q3	$206K	Hold	712	–	–	0.03%	316
2021 Q2	$142K	Hold	712	–	–	0.02%	330
2021 Q1	$138K	Hold	712	–	–	0.02%	348
2020 Q4	$136K	Hold	712	–	–	0.02%	360
2020 Q3	$105K	Hold	712	–	–	0.02%	370
2020 Q2	$88K	Hold	712	–	–	0.01%	332
2020 Q1	$69K	Hold	712	–	–	0.01%	319
2019 Q4	$66K	Buy	+712	New	+$59.8K	0.01%	398

Other funds holding RGEN

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Sands Capital Management Arlington, Virginia $25.5B AUM 26.46% 1-Year Est. Return

BCM

Brown Capital Management Baltimore, Maryland $500M AUM 25.3% 1-Year Est. Return

Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

Essex Investment Management's RGEN Position: Q2 2023 in Review

Essex Investment Management sold out of Repligen (RGEN) in Q2 2023, closing a stake of 178 shares — an estimated $30K sold.

Essex Investment Management first reported a position in RGEN in Q4 2019 and held it in 14 quarters. The position peaked at $206K in Q3 2021. 448 funds tracked by Wall St. Rank hold RGEN as of Q2 2023.

Essex Investment Management reported no remaining Repligen position as of Q2 2023 after selling out during the quarter.
Essex Investment Management sold 178 Repligen shares in Q2 2023, an estimated $30K.
Essex Investment Management first reported a position in Repligen in Q4 2019 and held it in 14 quarters.
Essex Investment Management's Repligen position peaked at $206K in Q3 2021.
448 funds tracked by Wall St. Rank held Repligen as of Q2 2023.

Based on Essex Investment Management's 13F filing for Q2 2023, filed 14 Aug 2023.